Quarterly report pursuant to Section 13 or 15(d)

Note 5 - Stock Incentive Plan (Details Textual)

v3.24.1.u1
Note 5 - Stock Incentive Plan (Details Textual) - USD ($)
3 Months Ended
Mar. 31, 2022
Apr. 30, 2020
Mar. 31, 2024
Mar. 31, 2023
Oct. 31, 2017
Apr. 30, 2016
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) [1]     10,000      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period (in shares) [2]     (0)      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value     $ 264,298      
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested     $ 2,556      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price (in dollars per share)     $ 4      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Outstanding, Weighted Average Exercise Price (in dollars per share)     4.24      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Outstanding, Weighted Average Exercise Price (in dollars per share)     $ 3.3      
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount     $ 2.5      
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)     2 years 3 months 3 days      
General and Administrative Expense [Member]            
Share-Based Payment Arrangement, Expense     $ 155,255 $ 244,337    
Research and Development Expense [Member]            
Share-Based Payment Arrangement, Expense     $ 173,406 $ 231,872    
Restricted Stock Units (RSUs) [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) [3]     0      
Options Held [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)     10,000      
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares) 5,100,000 3,100,000     1,600,000 700,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares) 2,000,000 1,500,000        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period (in shares)     0      
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Vesting Monthly Over One Year [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)     10,000      
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Month)     12 months      
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)     10 years      
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member] | Vesting Monthly Over One Year [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in dollars per share)     $ 0.3402      
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Restricted Stock [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)     0      
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)     0      
[1] 10,000 options vest as follows: options to purchase 10,000 shares of the Company’s common stock vest monthly over one year.
[2] There were no forfeitures during the three months ended March 31, 2024.
[3] There were no restricted stock units granted during the three months ended March 31, 2024.